FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

331821008: Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3692812014 Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3692814010 Betamethasone (as betamethasone valerate) 250 microgram/g cutaneous ointment en Synonym Active Entire term case insensitive SNOMED CT core module
46767001000001116 Betamethasone valerate 0.025% ointment en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Is a Product containing betamethasone in topical dosage form false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has active ingredient Adrenal hormone false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has active ingredient Corticosterone false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has active ingredient Adrenal hormone agent false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has active ingredient Glucocorticoid hormone false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has concentration strength denominator unit gram true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has precise active ingredient Betamethasone valerate true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Is a Product containing betamethasone valerate in topical dosage form false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has concentration strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has concentration strength numerator value 250 false Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Is a Product containing only betamethasone in cutaneous dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Cutaneous dose form true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has active ingredient Betamethasone valerate false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has active ingredient Betamethasone valerate false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Is a Betamethasone true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has specific active ingredient Betamethasone valerate true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has basis of strength substance Betamethasone false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Betamethasone 0.025% ointment - product Is a False Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betnovate RD 0.025% ointment (GlaxoSmithKline) Is a True Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betnovate RD 0.025% ointment (Mawdsley-Brooks & Company Ltd) Is a True Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betamethasone valerate 0.025% ointment 100 gram Is pack of False Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betamethasone valerate 0.025% ointment 100 gram Has VMP True Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betamethasone valerate 0.025% ointment (A A H Pharmaceuticals Ltd) Is a False Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Audavate RD 0.025% ointment (Accord Healthcare Ltd) Is a True Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start